SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-21
👔
Enliven Therapeutics, Inc.
@ELVN_InsiderForm 4 Filing: Hohl Benjamin Sells $319,438.888 of $ELVN
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
Enliven Therapeutics, Inc.
Ticker: $ELVN
Transaction Value
$319,438.888
Price/Share: $45.05
transaction date
2026-07-17
Shares: 7,090
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Hohl Benjamin, holds the title of CHIEF FINANCIAL OFFICER at Enliven Therapeutics, Inc..
On 2026-07-17, the insider transacted 7,090 shares.The shares were transacted at a weighted average price of $45.05 per share, resulting in a total market-relevant value of $319,438.888.
Executive Summary Summary
Hohl Benjamin (CHIEF FINANCIAL OFFICER) sold $319K of $ELVN
Post-Transaction Position: 46,177 shares
SEC Accession No: 0001882764-26-000006 (CIK: 1882764)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.